Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Ali

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|January 15, 2022
End compulsory drug treatment in the Asia-Pacific regionClaudia Stoicescu, Quinten Lataire, Karen Peters, et al.
Journal of Addiction Medicine|March 7, 2018
Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice GuidelinesNicholas Lintzeris, Lauren A Monds, Consuelo Rivas, et al.
Lancet (London, England)|November 1, 2019
Responding to global stimulant use: challenges and opportunitiesMichael Farrell, Natasha K Martin, Emily Stockings, et al.
Addiction (Abingdon, England)|December 1, 2011
A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countriesRachel Humeniuk, Robert Ali, Thomas Babor, et al.
Addiction (Abingdon, England)|October 17, 2020
Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian citiesSuzanne Nielsen, Paul Sanfilippo, Vendula Belackova, et al.
BMJ Open|July 22, 2018
LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependenceNadine Ezard, Adrian Dunlop, Michelle Hall, et al.
Drug and Alcohol Review|October 7, 2024
Provider costs of treating opioid dependence with extended-release buprenorphine in AustraliaStella Settumba, Jeyran Shahbazi, Marianne Byrne, et al.
Addiction (Abingdon, England)|April 1, 2008
Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST)Rachel Humeniuk, Robert Ali, Thomas F Babor, et al.
Addiction (Abingdon, England)|July 19, 2008
Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDSPeter Lawrinson, Robert Ali, Aumphornpun Buavirat, et al.
Addiction (Abingdon, England)|May 12, 2018
Global statistics on alcohol, tobacco and illicit drug use: 2017 status reportAmy Peacock, Janni Leung, Sarah Larney, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|January 15, 2022
End compulsory drug treatment in the Asia-Pacific regionClaudia Stoicescu, Quinten Lataire, Karen Peters, et al.
Journal of Addiction Medicine|March 7, 2018
Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice GuidelinesNicholas Lintzeris, Lauren A Monds, Consuelo Rivas, et al.
Lancet (London, England)|November 1, 2019
Responding to global stimulant use: challenges and opportunitiesMichael Farrell, Natasha K Martin, Emily Stockings, et al.
Addiction (Abingdon, England)|December 1, 2011
A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countriesRachel Humeniuk, Robert Ali, Thomas Babor, et al.
Addiction (Abingdon, England)|October 17, 2020
Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian citiesSuzanne Nielsen, Paul Sanfilippo, Vendula Belackova, et al.
BMJ Open|July 22, 2018
LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependenceNadine Ezard, Adrian Dunlop, Michelle Hall, et al.
Drug and Alcohol Review|October 7, 2024
Provider costs of treating opioid dependence with extended-release buprenorphine in AustraliaStella Settumba, Jeyran Shahbazi, Marianne Byrne, et al.
Addiction (Abingdon, England)|April 1, 2008
Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST)Rachel Humeniuk, Robert Ali, Thomas F Babor, et al.
Addiction (Abingdon, England)|July 19, 2008
Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDSPeter Lawrinson, Robert Ali, Aumphornpun Buavirat, et al.
Addiction (Abingdon, England)|May 12, 2018
Global statistics on alcohol, tobacco and illicit drug use: 2017 status reportAmy Peacock, Janni Leung, Sarah Larney, et al.
Pageof 12